Cannabinoids and arthritis

Reading this collection

Grouping these under one heading is a navigation convenience, not a clinical claim. Osteoarthritis is primarily degenerative and rheumatoid arthritis is autoimmune; a finding in one does not transfer to the other.

Much of the work in this cluster is preclinical or mechanistic. Where a record reports a human endpoint, its tier label says so.

The evidence in this library

5 source-linked studies — 5 scientific source. Each links to its source; identifiers are shown where the record carries them.

1. Cannabidiol as a Treatment for Arthritis and Joint Pain

   2022 · PMC / NCBI · CBD

   Scientific source

   PMID 35999581 · PMCID PMC9400326

2. CBD Anti-inflammatory Effects in Osteoarthritis — Chondroprotective via CB2

   2020 · PMC / NCBI · CBD

   Scientific source

   PMCID PMC7339825

3. CBD and THC combination for rheumatoid arthritis pain

   NCBI

   Scientific source

   PMID 33945704

4. Cannabinoid therapy improves quality of life in arthritis

   NCBI

   Scientific source

   PMID 33888504

5. Full-spectrum reduces inflammatory markers in RA

   NCBI

   Scientific source

   PMID 32612598

How to read this evidence

These are the boundaries recorded against the studies above, reproduced as written in the library:

• Mechanistic/symptom-support rationale only; avoid disease-cure or product-specific proof unless clinical endpoint exists.
• Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.